drugset / Trial / NCT00960193

Drug-Food Interaction Study of Seville Orange Juice and Colchicine

NCT00960193

Phase 1 Completed 24 enrolled Mutual Pharmaceutical Company, Inc.
Non-randomizedSingle-groupOpen-labelBasic science

Summary

Seville orange juice is an inhibitor of the intestinal cytochrome P450 (CYP) 3A4 enzyme, one of the enzymes responsible for the metabolism of colchicine. This study will evaluate the effect of multiple daily consumptions of Seville orange juice on the pharmacokinetic profile of a single 0.6 mg dose of colchicine. A secondary objective is to evaluate the safety and tolerability of this regimen in healthy volunteers. All study subjects will be monitored for adverse events throughout the study period.

Timeline

Start
2009-02
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral

Indications

No indication recorded.